Literature DB >> 15104250

Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease.

Marieke E van Meeteren1, Jerome J A Hendriks, Christine D Dijkstra, Eric A F van Tol.   

Abstract

Oligodendrocytes and activated macrophages are involved in the immunopathology of demyelinating disease. In this study, we investigated the in vitro effect of dietary compounds, in particular flavonoids, on oxidative damage in OLN-93 oligodendrocytes and on nitric oxide (NO) production by NR8383 macrophages. Using a cell viability assay, we found the flavonoids luteolin and quercetin to protect OLN-93 cells against hydrogen peroxide-induced oxidative damage. Furthermore, apigenin and luteolin, but not morin inhibited NO production and reduced the expression of inducible NO synthase (iNOS) protein in lipopolysaccharide (LPS)-stimulated NR8383 macrophages. It was found that those dietary compounds effective in preventing oxidative damage in OLN-93 oligodendrocytes were not necessarily effective in reducing NO production and iNOS protein expression in NR8383 macrophages and vice versa. The different properties of the dietary compounds tested in this paper make them potential anti-inflammatory agents targeting neurodegenerative and neuroinflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104250     DOI: 10.1016/j.bcp.2003.10.018

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

Review 1.  A review on the role of nutraceuticals as simple as se(2+) to complex organic molecules such as glycyrrhizin that prevent as well as cure diseases.

Authors:  Regi Jose; G R Sajitha; K T Augusti
Journal:  Indian J Clin Biochem       Date:  2013-07-23

2.  Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Heejeong Kim; Charlotte Stanford; Govardhan Rathnaiah; David Steffen; Jaekwon Lee; Jay Reddy
Journal:  J Neuroimmunol       Date:  2013-01-05       Impact factor: 3.478

Review 3.  The influence of nutritional factors on the prognosis of multiple sclerosis.

Authors:  Gloria von Geldern; Ellen M Mowry
Journal:  Nat Rev Neurol       Date:  2012-10-02       Impact factor: 42.937

Review 4.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

5.  Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.

Authors:  Sarah Neil; Jaebong Huh; Victoria Baronas; Xinhui Li; Henry F McFarland; Murali Cherukuri; James B Mitchell; Jacqueline A Quandt
Journal:  Brain Behav Immun       Date:  2017-02-24       Impact factor: 7.217

6.  Dietary terpenoids and prostate cancer chemoprevention.

Authors:  Thangaiyan Rabi; Sanjay Gupta
Journal:  Front Biosci       Date:  2008-05-01

7.  Neuroprotective Effects of Melatonin on Experimental Allergic Encephalomyelitis Mice Via Anti-Oxidative Stress Activity.

Authors:  Ting Long; Yuan Yang; Ling Peng; Zuoxiao Li
Journal:  J Mol Neurosci       Date:  2018-02-15       Impact factor: 3.444

8.  Hydrogen-Rich Saline Ameliorates Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice Via the Nrf2-ARE Signaling Pathway.

Authors:  Yaping Liu; Fuxing Dong; Rui Guo; Ying Zhang; Xuebin Qu; Xiuxiang Wu; Ruiqin Yao
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

9.  Daphnetin Ameliorates Experimental Autoimmune Encephalomyelitis Through Regulating Heme Oxygenase-1.

Authors:  Dan Wang; Bo Zhu; Xiaoyi Liu; Qin Han; Weihong Ge; Wenping Zhang; Yin Lu; Qinan Wu; Liyun Shi
Journal:  Neurochem Res       Date:  2020-01-16       Impact factor: 3.996

10.  Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.

Authors:  De-Hyung Lee; Ralf Gold; Ralf A Linker
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.